Catalyst Pharmaceuticals CPRX Stock
Catalyst Pharmaceuticals Price Chart
Catalyst Pharmaceuticals CPRX Financial and Trading Overview
| Catalyst Pharmaceuticals stock price | 31.48 USD |
| Previous Close | 31.47 USD |
| Open | 31.47 USD |
| Bid | 31.47 USD x 1900 |
| Ask | 31.48 USD x 2200 |
| Day's Range | 31.47 - 31.48 USD |
| 52 Week Range | 19.05 - 32.56 USD |
| Volume | 579.98K USD |
| Avg. Volume | 2.41M USD |
| Market Cap | 3.85B USD |
| Beta (5Y Monthly) | 0.742 |
| PE Ratio (TTM) | 18.196531 |
| EPS (TTM) | 1.73 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 31.67 USD |
CPRX Valuation Measures
| Enterprise Value | 3.1B USD |
| Trailing P/E | 18.196531 |
| Forward P/E | 9.896041 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 6.455565 |
| Price/Book (mrq) | 3.7982624 |
| Enterprise Value/Revenue | 5.19 |
| Enterprise Value/EBITDA | 10.13 |
Trading Information
Catalyst Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | 0.742 |
| 52-Week Change | 44.29% |
| S&P500 52-Week Change | 20.51% |
| 52 Week High | 32.56 USD |
| 52 Week Low | 19.05 USD |
| 50-Day Moving Average | 31.04 USD |
| 200-Day Moving Average | 25.17 USD |
CPRX Share Statistics
| Avg. Volume (3 month) | 2.41M USD |
| Avg. Daily Volume (10-Days) | 2.16M USD |
| Shares Outstanding | 122.42M |
| Float | 115.58M |
| Short Ratio | 4.11 |
| % Held by Insiders | 5.57% |
| % Held by Institutions | 89.57% |
| Shares Short | 7.85M |
| Short % of Float | 6.78% |
| Short % of Shares Outstanding | 6.41% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 37.07% |
| Operating Margin (ttm) | 49.02% |
| Gross Margin | 84.03% |
| EBITDA Margin | 51.23% |
Management Effectiveness
| Return on Assets (ttm) | 16.26% |
| Return on Equity (ttm) | 24.49% |
Income Statement
| Revenue (ttm) | 596.96M USD |
| Revenue Per Share (ttm) | 4.87 USD |
| Quarterly Revenue Growth (yoy) | 5.60% |
| Gross Profit (ttm) | 501.66M USD |
| EBITDA | 305.83M USD |
| Net Income Avi to Common (ttm) | 221.32M USD |
| Diluted EPS (ttm) | 1.73 |
| Quarterly Earnings Growth (yoy) | 12.30% |
Balance Sheet
| Total Cash (mrq) | 755.86M USD |
| Total Cash Per Share (mrq) | 6.18 USD |
| Total Debt (mrq) | 2.68M USD |
| Total Debt/Equity (mrq) | 0.27 USD |
| Current Ratio (mrq) | 7.103 |
| Book Value Per Share (mrq) | 8.288 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 208.21M USD |
| Levered Free Cash Flow (ttm) | 171.81M USD |
Profile of Catalyst Pharmaceuticals
| Country | United States |
| State | FL |
| City | Coral Gables |
| Address | 355 Alhambra Circle |
| ZIP | 33134 |
| Phone | 305 420 3200 |
| Website | https://catalystpharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 182 |
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States. It offers Firdapse for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); Fycompa, a novel non-competitive selective antagonist at the postsynaptic ionotropic alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid glutamate receptor that is used to treat focal onset seizures, as well as tonic-clonic seizure; and AGAMREE, a corticosteroid for the treatment of duchenne muscular dystrophy. The company has license agreements with BioMarin Pharmaceutical Inc.; and a collaboration and license agreement with Endo Ventures Limited for the development and commercialization of generic Sabril tablets. Catalyst Pharmaceuticals, Inc. was founded in 2002 and is based in Coral Gables, Florida.
Q&A For Catalyst Pharmaceuticals Stock
What is a current CPRX stock price?
Catalyst Pharmaceuticals CPRX stock price today per share is 31.48 USD.
How to purchase Catalyst Pharmaceuticals stock?
You can buy CPRX shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Catalyst Pharmaceuticals?
The stock symbol or ticker of Catalyst Pharmaceuticals is CPRX.
Which industry does the Catalyst Pharmaceuticals company belong to?
The Catalyst Pharmaceuticals industry is Biotechnology.
How many shares does Catalyst Pharmaceuticals have in circulation?
The max supply of Catalyst Pharmaceuticals shares is 122.42M.
What is Catalyst Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
Catalyst Pharmaceuticals PE Ratio is 18.19653100 now.
What was Catalyst Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
Catalyst Pharmaceuticals EPS is 1.73 USD over the trailing 12 months.
Which sector does the Catalyst Pharmaceuticals company belong to?
The Catalyst Pharmaceuticals sector is Healthcare.
Catalyst Pharmaceuticals CPRX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
25873.18 USD — |
-1.55
|
6.31B USD — | 25822.1 USD — | 26139.37 USD — | — - | 6.31B USD — |
|
US Tech Capital Market Composite
RCMP
US
|
138.78 USD — |
-2.69
|
— — | 138.28 USD — | 141.36 USD — | — - | — — |
|
US Tech AlphaDEX Multi Cap Growt
NQDXUSMLTCG
US
|
4006.39 USD — |
-1.69
|
— — | 3993.97 USD — | 4049.67 USD — | — - | — — |
|
US Tech Health Care
IXHC
US
|
1254.95 USD — |
-1.05
|
— — | 1250.11 USD — | 1262.34 USD — | — - | — — |
|
US Tech Composite Total Return
XCMP
US
|
31918 USD — |
-1.55
|
— — | 31854.98 USD — | 32246.38 USD — | — - | — — |
|
US Tech US 700 Small Cap Index
NQUS700SC
US
|
3154.19 USD — |
-0.65
|
— — | 3147.71 USD — | 3174.71 USD — | — - | — — |
- {{ link.label }} {{link}}